share_log

BioAffinity Technologies Receives Additional $7.7M From Exercise Of Warrants

BioAffinity Technologies Receives Additional $7.7M From Exercise Of Warrants

生物親和技術公司通過行使認股權證獲得額外770萬美元
Benzinga Real-time News ·  2022/09/28 08:16

$bioAffinity Technologies (BIAF.US)$ today announced the receipt of approximately $7.7 million in additional gross proceeds from the exercise of tradeable and non-tradable warrants issued in the Company's September 6, 2022, public offering of securities.

$bioAffinity Technologies (BIAF.US)$今天宣佈從行使可交易和不可交易認股權證中獲得約770萬美元的額外毛收入,這些認股權證是在公司2022年9月6日公開發售證券時發行的。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論